Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 08:32 am Sale |
2024-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 3,100,000 3.410% |
-4,535,000 (-59.40%) |
Filing History |
| 2025-02-10 10:25 am Sale |
2024-12-31 | 13G | Myriad Genetics, Inc. MYGN |
WELLINGTON MANAGEMENT CO LLP | 6,004,598 6.600% |
-1,215,108 (-16.83%) |
Filing History |
| 2024-11-14 4:16 pm Sale |
2024-09-30 | 13G | Myriad Genetics, Inc. MYGN |
GLENVIEW CAPITAL MANAGEMENT LLC | 1,261,530 1.390% |
-4,022,452 (-76.13%) |
Filing History |
| 2024-05-01 4:21 pm Purchase |
2024-04-25 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 4,544,150 5.000% |
50,889 (+1.13%) |
Filing History |
| 2024-04-25 4:18 pm Purchase |
2024-04-17 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 4,493,261 4.970% |
931,924 (+26.17%) |
Filing History |
| 2024-03-18 4:39 pm Purchase |
2024-03-12 | 13G | Myriad Genetics, Inc. MYGN |
MILLENNIUM MANAGEMENT LLC | 4,262,021 4.700% |
4,262,021 (New Position) |
Filing History |
| 2024-02-14 4:47 pm Purchase |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
GLENVIEW CAPITAL MANAGEMENT LLC | 5,283,982 5.970% |
971,851 (+22.54%) |
Filing History |
| 2024-02-14 08:24 am Purchase |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 7,635,000 8.500% |
635,000 (+9.07%) |
Filing History |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 9,954,233 11.120% |
642,472 (+6.90%) |
Filing History |
| 2024-02-08 10:14 am Purchase |
2023-12-29 | 13G | Myriad Genetics, Inc. MYGN |
WELLINGTON MANAGEMENT CO LLP | 7,219,706 8.070% |
432,483 (+6.37%) |
Filing History |
| 2024-01-24 1:20 pm Sale |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
STATE STREET CORP STT |
4,700,631 5.250% |
-319,792 (-6.37%) |
Filing History |
| 2024-01-23 4:31 pm Sale |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 3,561,337 4.000% |
-699,704 (-16.42%) |
Filing History |
| 2024-01-22 2:03 pm Purchase |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BLACKROCK INC BLK |
14,658,349 16.600% |
302,250 (+2.11%) |
Filing History |
| 2023-10-17 4:14 pm Purchase |
2023-10-10 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 4,261,041 5.200% |
4,261,041 (New Position) |
Filing History |
| 2023-03-01 4:10 pm Purchase |
2023-02-24 | 13G | Myriad Genetics, Inc. MYGN |
GLENVIEW CAPITAL MANAGEMENT LLC | 4,312,131 5.310% |
4,312,131 (New Position) |
Filing History |
| 2023-02-14 08:46 am Purchase |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 7,000,000 8.640% |
2,300,000 (+48.94%) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 9,311,761 11.490% |
162,240 (+1.77%) |
Filing History |
| 2023-02-06 2:53 pm Purchase |
2022-12-30 | 13G | Myriad Genetics, Inc. MYGN |
WELLINGTON MANAGEMENT CO LLP | 6,787,223 8.380% |
2,461,448 (+56.90%) |
Filing History |
| 2023-01-31 09:19 am Purchase |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
STATE STREET CORP STT |
5,020,423 6.200% |
610,020 (+13.83%) |
Filing History |
| 2023-01-23 3:52 pm Sale |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
BLACKROCK INC BLK |
14,356,099 17.700% |
-328,688 (-2.24%) |
Filing History |